2m 2m 2m 2m 2m 2m 2m
ARRIVENT BIO (AVBP)
NASDAQ
$28.38-$0.55 (-1.92%)
Price as of Oct 02, 2026 5:07 PM EDT- $1.4BMarket Cap
- 53.64%1-Year Change
- BiotechnologyIndustry
ARRIVENT BIO (AVBP)
$28.38-$0.55 (-1.92%)
AVBP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.93 | ||
Change | -$1.35 (-4.46%) | ||
Open | $29.99 | ||
High | $30.64 | ||
Low | $28.81 | ||
Previous Close | $30.28 | ||
Volume | 591,789 | ||
30-Day Average Volume | 635,076 | ||
1-Week Change | -3.89% | ||
1-Month Change | -4.05% | ||
1-Year Change | 53.64% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 49.3M | ||
Total Assets | $394.7M | ||
Market Cap | $1.4B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$49.9M | ||
Free Cash Flow | -$39.6M | ||
EBIT | -$49.9M | ||
EBITDA | -$50.4M | ||
Net Working Capital | $366.3M | ||
EPS | -$1.05 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -28 | ||
PEG | 3 | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue